This report outlines KPMG viewpoints, as well as those of senior executives in China’s life sciences sector, on the prospects of the industry.
© 2017 KPMG Huazhen LLP — a People's Republic of China partnership, KPMG Advisory (China) Limited — a wholly foreign owned enterprise in China, and KPMG — a Hong Kong partnership, are member firms of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. The KPMG name and logo are registered trademarks or trademarks of KPMG International.
KPMG International has created a state of the art digital platform that enhances your experience, optimized to discover new and related content.